PTC Therapeutics Inc banner

DCF Value

The DCF Value for PTC Therapeutics Inc (BH3) under the Base Case is 48.62 EUR. Compared with the current market price of 55.18 EUR, the stock appears Overvalued by 12% .

Key assumptions
BH3 DCF Value
Base Case
€48.62
Overvaluation 12%
DCF Value
Price €55.18
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time